Effects of fludarabine and gemcitabine on human acute myeloid leukemia cell line HL 60: Direct comparison of cytotoxicity and cellular Ara-C uptake enhancement
- 31 January 1996
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 20 (1) , 37-45
- https://doi.org/10.1016/0145-2126(95)00106-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.Journal of Clinical Oncology, 1993
- Features of apoptotic cells measured by flow cytometryCytometry, 1992
- Comparison of antineoplastic activity of cytosine arafolnoside and 2',2'-difluorodeoxycytidine on human myeloid, T-cell and B-ceil leukemic cellsEuropean Journal of Pharmacology, 1990
- Saturation of intracellular cytosine arabinoside triphosphate accumulation in human leukemic blast cellsLeukemia Research, 1989
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaBlood, 1989
- Inhibition of DNA synthesis by cytosine arabinoside: Relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the diseaseEuropean Journal of Cancer and Clinical Oncology, 1984
- Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic cellsBlood, 1984
- Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB studyBlood, 1982
- Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytesBlood, 1975
- Treatment of acute leukemia in adultsCancer, 1975